Comparing home-based and hospital-based pulmonary rehabilitation for bronchiectasis
Official title: Comparison of Pulmonary Rehabilitation Efficiency in Home-based With Hospital-based Pulmonary Rehabilitation in Bronchiectasis
Run by Istanbul Medipol University Hospital · NCT03561818 · Data updated 2026-11-12
This study is testing whether doing pulmonary rehabilitation at home or in the hospital is better for people with bronchiectasis to see which helps them breathe easier and feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Istanbul Medipol University Hospital Academic / other |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Status | Recruiting |
| Started | June 19, 2018 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT03561818 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-70 with stable bronchiectasis diagnosed via high-resolution computed tomography.
✕Probably not a fit
Patients with decompensated heart failure, uncontrolled hypertension, or other conditions that may hinder exercise will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the effectiveness of home-based pulmonary rehabilitation (PR) versus hospital-based PR in patients with bronchiectasis. While PR has shown benefits in chronic obstructive pulmonary disease (COPD), its efficacy in bronchiectasis is less understood, necessitating further investigation. The study will assess pulmonary function, dyspnea perception, quality of life, and exercise capacity before and after the rehabilitation programs. By evaluating both supervised and unsupervised PR methods, the research seeks to determine the most effective approach for improving patient outcomes.
Why it matters
Potential benefit: If successful, this study could provide insights into more accessible and effective rehabilitation options for patients with bronchiectasis.
How similar studies have gone: While some studies have shown positive effects of pulmonary rehabilitation in bronchiectasis, this specific comparison of home-based versus hospital-based approaches is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between the ages of 18-70 * Patients signing informed consent form * Bronchiectasis patients in the stable phase who were diagnosed with High-resolution computed tomography (HRCT). Exclusion Criteria: * Decompensated heart failure, uncontrolled hypertension (Systolic Blood Pressure\> 200, Diastolic Blood Pressure\> 110), * Additional diseases that may prevent exercise, * To be regularly exercising regularly
Where it's running
-
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Esra Pehlivan, PhD
- Email: fztesrakambur@yahoo.com
- Phone: +905058527913
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using cough samples to analyze lung health
This study is testing whether cough samples can help us find signs of lung diseases by comparing them to samples taken from healthy people and smokers.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Breathlessness in respiratory diseases: who feels it and why
This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.
-
Hypertonic saline inhalation for NTM lung disease
This trial tests whether starting inhaled 3% hypertonic saline early helps people with non-tuberculous mycobacterial lung disease feel better and clear bacteria better, compared with starting with normal saline first.
-
Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups
This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.